Literature DB >> 6851421

Changes in the binding of radioactive conjugated bile salts to serum proteins in cholestatic jaundice.

A Chitranukroh, B H Billing.   

Abstract

1. A micro-partition centrifugal ultrafiltration technique has been used to monitor the percentage of [14C]glycocholate, [3H]glycochenodeoxycholate and [3H]glycochenodeoxycholate-3-sulphate bound to serum proteins of patients with cholestatic liver disease. 2. In comparison with normal individuals the percentage of binding of [14C]glycocholate and, to a lesser extent, of [3H]glycochenodeoxycholate and [3H]glycochenodeoxycholate-3-sulphate was reduced. 3. The binding of [14C]glycocholate was inversely related to the serum bile salt and bilirubin concentrations. In contrast, the binding of [3H]glycochenodeoxycholate and [3H]glycochenodeoxycholate-3-sulphate were not altered by the severity of the cholestasis. 4. Studies in vitro indicated that the reduction in the binding of [14C]glycocholate in cholestatic liver disease was not due to high concentrations of bile salts, unconjugated bilirubin or fatty acids.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6851421     DOI: 10.1042/cs0650077

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  3 in total

1.  Studies on the origin of biliary phospholipid. Effect of dehydrocholic acid and cholic acid infusions on hepatic and biliary phospholipids.

Authors:  F Chanussot; H Lafont; J Hauton; B Tuchweber; I Yousef
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

2.  Effects of bile acids on ventricular muscle contraction and electrophysiological properties: studies in rat papillary muscle and isolated ventricular myocytes.

Authors:  O Binah; I Rubinstein; A Bomzon; O S Better
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-02       Impact factor: 3.000

3.  Effect of crilvastatin, a new cholesterol lowering agent, on unesterified LDL-cholesterol metabolism into bile salts by rat isolated hepatocytes.

Authors:  T Clerc; V Sbarra; N Diaconescu; H Lafont; G Jadot; C Laruelle; F Chanussot
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.